Report cover image

Postpartum Hemorrhage (PPH) Devices Market By Product (Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, Uterine Tamponade Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030

Publisher Allied Market Research
Published Apr 01, 2022
Length 205 Pages
SKU # ALMR17334570

Description

Postpartum Hemorrhage (PPH) Devices Market By Product (Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, Uterine Tamponade Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030

Postpartum hemorrhage (PPH), defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries. Primary PPH is  characterized by blood loss that occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery. Poor uterine conditions, which include failure of uterus to contract after childbirth is primarily the reason for PPH and thus, the demand for modern PPH treatment devices outpace the traditional methods, due to the fact that these devices aim toward healing the uterine conditions and problems of uterus contractions.

Rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and surge in pregnancy related complications drive the growth of the market. Moreover, increase in number of education and training initiatives by the government on PPH propels the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries restrain the growth of the market. 

Postpartum hemorrhage device market is segmented on the basis of on product and region . Product segment is classified  into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is fragmented into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major companies profiled in this report include, 3rd Stone Design, Bactiguard AB,  Becton, Dickinson and company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, Utah Medical Products, Inc., and Zoex.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the postpartum hemorrhage devices industry, market segments, current trends, estimations, and dynamics of the postpartum hemorrhage (pph) devices market analysis from 2020 to 2030 to identify the prevailing postpartum hemorrhage devices market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the postpartum hemorrhage (pph) devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global postpartum hemorrhage devices industry, market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Product

Non-Pneumatic Anti-Shock Garment
Prefilled Injection System
Uterine Tamponade Devices
Foley Catheter
Condom Catheter
Balloon Tamponade
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
U.K.
Italy
Spain
Rest of Europe
Germany
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Utah Medical Products, Inc.
BD
Cook
Teleflex Incorporated
BACTIGUARD AB
PATH
3rd Stone Design
ZOEX
ORGANON
OBSTETRX
Clinical Innovations, LLC.

Table of Contents

205 Pages
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Non-Pneumatic Anti-Shock Garment
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Prefilled Injection System
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Uterine Tamponade Devices
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Product
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Product
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Product
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Product
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Product
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Product
5.4.3.3 Australia
5.4.3.3.1 Market size and forecast, by Product
5.4.3.4 India
5.4.3.4.1 Market size and forecast, by Product
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Product
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Product
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Product
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Product
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Utah Medical Products, Inc.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 BD
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Cook
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Teleflex Incorporated
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 BACTIGUARD AB
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 PATH
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 3rd Stone Design
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 ZOEX
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 ORGANON
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 OBSTETRX
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
7.11 Clinical Innovations, LLC.
7.11.1 Company overview
7.11.2 Company snapshot
7.11.3 Operating business segments
7.11.4 Product portfolio
7.11.5 Business performance
7.11.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 2. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION , 2020-2030,($MILLION)
TABLE 3. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET NON-PNEUMATIC ANTI-SHOCK GARMENT BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR PREFILLED INJECTION SYSTEM, BY REGION , 2020-2030,($MILLION)
TABLE 5. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET PREFILLED INJECTION SYSTEM BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET REVENUE, FOR UTERINE TAMPONADE DEVICES, BY REGION , 2020-2030,($MILLION)
TABLE 7. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET UTERINE TAMPONADE DEVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 9. NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 10. NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. U.S. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 12. CANADA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 13. MEXICO POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 14. EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 15. EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. GERMANY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 17. FRANCE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 18. U.K. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 19. ITALY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 20. SPAIN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 21. REST OF EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 22. ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 23. ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. JAPAN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 25. CHINA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 26. AUSTRALIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 27. INDIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 28. SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 29. REST OF ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 30. LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 31. LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 32. BRAZIL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 33. SAUDI ARABIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 34. SOUTH AFRICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 35. REST OF LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 36.UTAH MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT
TABLE 37.UTAH MEDICAL PRODUCTS, INC.: OPERATING SEGMENTS
TABLE 38.UTAH MEDICAL PRODUCTS, INC.: PRODUCT PORTFOLIO
TABLE 39.UTAH MEDICAL PRODUCTS, INC.: NET SALES,
TABLE 40.UTAH MEDICAL PRODUCTS, INC.: KEY STRATERGIES
TABLE 41.BD: COMPANY SNAPSHOT
TABLE 42.BD: OPERATING SEGMENTS
TABLE 43.BD: PRODUCT PORTFOLIO
TABLE 44.BD: NET SALES,
TABLE 45.BD: KEY STRATERGIES
TABLE 46.COOK: COMPANY SNAPSHOT
TABLE 47.COOK: OPERATING SEGMENTS
TABLE 48.COOK: PRODUCT PORTFOLIO
TABLE 49.COOK: NET SALES,
TABLE 50.COOK: KEY STRATERGIES
TABLE 51.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 52.TELEFLEX INCORPORATED: OPERATING SEGMENTS
TABLE 53.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 54.TELEFLEX INCORPORATED: NET SALES,
TABLE 55.TELEFLEX INCORPORATED: KEY STRATERGIES
TABLE 56.BACTIGUARD AB: COMPANY SNAPSHOT
TABLE 57.BACTIGUARD AB: OPERATING SEGMENTS
TABLE 58.BACTIGUARD AB: PRODUCT PORTFOLIO
TABLE 59.BACTIGUARD AB: NET SALES,
TABLE 60.BACTIGUARD AB: KEY STRATERGIES
TABLE 61.PATH: COMPANY SNAPSHOT
TABLE 62.PATH: OPERATING SEGMENTS
TABLE 63.PATH: PRODUCT PORTFOLIO
TABLE 64.PATH: NET SALES,
TABLE 65.PATH: KEY STRATERGIES
TABLE 66.3RD STONE DESIGN: COMPANY SNAPSHOT
TABLE 67.3RD STONE DESIGN: OPERATING SEGMENTS
TABLE 68.3RD STONE DESIGN: PRODUCT PORTFOLIO
TABLE 69.3RD STONE DESIGN: NET SALES,
TABLE 70.3RD STONE DESIGN: KEY STRATERGIES
TABLE 71.ZOEX: COMPANY SNAPSHOT
TABLE 72.ZOEX: OPERATING SEGMENTS
TABLE 73.ZOEX: PRODUCT PORTFOLIO
TABLE 74.ZOEX: NET SALES,
TABLE 75.ZOEX: KEY STRATERGIES
TABLE 76.ORGANON: COMPANY SNAPSHOT
TABLE 77.ORGANON: OPERATING SEGMENTS
TABLE 78.ORGANON: PRODUCT PORTFOLIO
TABLE 79.ORGANON: NET SALES,
TABLE 80.ORGANON: KEY STRATERGIES
TABLE 81.OBSTETRX: COMPANY SNAPSHOT
TABLE 82.OBSTETRX: OPERATING SEGMENTS
TABLE 83.OBSTETRX: PRODUCT PORTFOLIO
TABLE 84.OBSTETRX: NET SALES,
TABLE 85.OBSTETRX: KEY STRATERGIES
TABLE 86.CLINICAL INNOVATIONS, LLC.: COMPANY SNAPSHOT
TABLE 87.CLINICAL INNOVATIONS, LLC.: OPERATING SEGMENTS
TABLE 88.CLINICAL INNOVATIONS, LLC.: PRODUCT PORTFOLIO
TABLE 89.CLINICAL INNOVATIONS, LLC.: NET SALES,
TABLE 90.CLINICAL INNOVATIONS, LLC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET SEGMENTATION
FIGURE 2.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030
FIGURE 3.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,BY PRODUCT,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF NON-PNEUMATIC ANTI-SHOCK GARMENT POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PREFILLED INJECTION SYSTEM POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF UTERINE TAMPONADE DEVICES POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030(%)
FIGURE 15.POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET BY REGION,2020
FIGURE 16.U.S. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 17.CANADA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 18.MEXICO POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 19.GERMANY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 20.FRANCE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 21.U.K. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 22.ITALY POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 23.SPAIN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 24.REST OF EUROPE POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 25.JAPAN POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 26.CHINA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 27.AUSTRALIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 28.INDIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 29.SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 30.REST OF ASIA-PACIFIC POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 31.BRAZIL POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 32.SAUDI ARABIA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 33.SOUTH AFRICA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 34.REST OF LAMEA POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET,2020-2030($MILLION)
FIGURE 35. TOP WINNING STRATEGIES, BY YEAR
FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 38.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 39.COMPETITIVE DASHBOARD
FIGURE 40.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 41.UTAH MEDICAL PRODUCTS, INC..: NET SALES ,($MILLION)
FIGURE 42.BD.: NET SALES ,($MILLION)
FIGURE 43.COOK.: NET SALES ,($MILLION)
FIGURE 44.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)
FIGURE 45.BACTIGUARD AB.: NET SALES ,($MILLION)
FIGURE 46.PATH.: NET SALES ,($MILLION)
FIGURE 47.3RD STONE DESIGN.: NET SALES ,($MILLION)
FIGURE 48.ZOEX.: NET SALES ,($MILLION)
FIGURE 49.ORGANON.: NET SALES ,($MILLION)
FIGURE 50.OBSTETRX.: NET SALES ,($MILLION)
FIGURE 51.CLINICAL INNOVATIONS, LLC..: NET SALES ,($MILLION)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us